TCGX Acquisition Corp. II Announces Pricing of $100,000,000 Initial Public Offering

PALO ALTO, Calif.–(BUSINESS WIRE)– #Biotechnology–TCGX Acquisition Corp. II (the “Company”) announced today that it priced its initial public offering of 10,000,000 Class A ordinary shares at a price of $10.00 per share, for gross proceeds of $100,000,000. Unlike certain other special purpose acquisition company initial public offerings, investors in this offering will not receive warrants that would become exercisable following the completion of the Company’s initial business combination.The Class A ordinary

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.